| 1. | Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol, 2019, 5(12): 1749-1768. | 
				                                                        
				                                                            
				                                                                | 2. | 程晨, 吳云樺, 徐正水, 等. Ⅱ~Ⅲ期結腸癌根治術后復發危險因素分析及其列線圖預測模型的應用價值. 中華消化外科雜志, 2021, 20(3): 331-338. | 
				                                                        
				                                                            
				                                                                | 3. | 段麗寧, 常寧, 趙亞靜, 等. 血清腫瘤標志物聯合肝功能指標檢測對結腸癌肝轉移的診斷價值. 中華腫瘤防治雜志, 2022, 29(16): 1206-1210. | 
				                                                        
				                                                            
				                                                                | 4. | Giannis D, Sideris G, Kakos CD, et al. The role of liver transplantation for colorectal liver metastases: a systematic review and pooled analysis. Transplant Rev (Orlando), 2022, 34(4): 100570. doi: 10.1016/j.trre.2020.100570. | 
				                                                        
				                                                            
				                                                                | 5. | Wang X, He Q, Liang H, et al. A novel robust nomogram based on preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) for predicting lymph node metastasis of gastric cancer. J Gastrointest Oncol, 2021, 12(6): 2706-2718. | 
				                                                        
				                                                            
				                                                                | 6. | Feng JF, Wang L, Yang X. The preoperative hemoglobin, albumin, lymphocyte and platelet (HALP) score is a useful predictor in patients with resectable esophageal squamous cell carcinoma. Bosn J Basic Med Sci, 2021, 21(6): 773-781. | 
				                                                        
				                                                            
				                                                                | 7. | Wei S, Shao J, Wang J, et al. The preoperative hemoglobin, albumin, lymphocyte, and platelet score is a prognostic factor for non-small cell lung cancer patients undergoing adjuvant chemotherapy: a retrospective study. Ann Transl Med, 2022, 10(8): 457. doi: 10.21037/atm-22-1097. | 
				                                                        
				                                                            
				                                                                | 8. | Polk N, Budai B, Hitre E, et al. Corrigendum: high neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) are markers of longer survival after metastasectomy of patients with liver-only metastasis of rectal cancer. Pathol Oncol Res, 2022, 28: 1610658. doi: 10.3389/pore.2022.1610658. | 
				                                                        
				                                                            
				                                                                | 9. | 趙伽木, 張偉, 周洪淵, 等. 結直腸癌肝轉移的最新研究進展. 中華肝臟外科雜志, 2021, 2(27): 156-160. | 
				                                                        
				                                                            
				                                                                | 10. | 俞甲子, 張明元, 金梁斌, 等. 結直腸癌不同部位的原發灶對肝轉移瘤根治切除術后早期復發的影響. 中華普通外科雜志, 2022, 37(6): 434-438. | 
				                                                        
				                                                            
				                                                                | 11. | Zhang L, Qiao L, Zhang M, et al. Comparison of prognosis among patients with colorectal cancer liver metastases treated by surgical resection, radiofrequency ablation and HIFU: a protocol for network meta-analysis. Medicine (Baltimore), 2022, 101(33): e27915. doi: 10.1097/MD.0000000000027915. | 
				                                                        
				                                                            
				                                                                | 12. | Zhang L, Zhang Z, Guo H, et al. Systemic immune-inflammation index: a new indicator of predicting 1-, 2-and 3-year disease-free survival of patients with colon cancer. Adv Clin Exp Med, 2022, 32(1): 13-22. | 
				                                                        
				                                                            
				                                                                | 13. | Belcher DA, Lucas A, Cabrales P, et al. Polymerized human hemoglobin facilitated modulation of tumor oxygenation is dependent on tumor oxygenation status and oxygen affinity of the hemoglobin-based oxygen carrier. Sci Rep, 2020, 10(1): 11372. doi: 10.1038/s41598-020-68190-0. | 
				                                                        
				                                                            
				                                                                | 14. | Cheong CM, Golder AM, Horgan PG, et al. Relationship between pre-operative glycated haemoglobin and surgical site infection in patients undergoing elective colon cancer surgery. Oncol Lett, 2022, 24(3): 296. doi: 10.3892/ol.2022.13416. | 
				                                                        
				                                                            
				                                                                | 15. | Xie H, Wei L, Liu M, et al. Neutrophil-albumin ratio as a biomarker for postoperative complications and long-term prognosis in patients with colorectal cancer undergoing surgical treatment. Front Nutr, 2022, 15(9): 976216. doi: 10.3389/fnut.2022.976216. | 
				                                                        
				                                                            
				                                                                | 16. | 袁夢依, 王培山, 孟瑞霞, 等. 術前 HALP 評分對老年非小細胞肺癌手術病人預后的預測價值. 實用老年醫學, 2022, 12(36): 1259-1263. | 
				                                                        
				                                                            
				                                                                | 17. | Hajibandeh S, Barghash M, Khan RMA, et al. Predictive significance of tumour size in patients undergoing curative surgery for colorectal cancer: a retrospective cohort study. Cureus, 2022, 14(7): e26656. doi: 10.7759/cureus.26656. | 
				                                                        
				                                                            
				                                                                | 18. | Aylward C, Noori J, Tyrrell J, et al. Survival outcomes after synchronous para-aortic lymph node metastasis in colorectal cancer: a systematic review. J Surg Oncol, 2023, 127(4): 645-656. | 
				                                                        
				                                                            
				                                                                | 19. | 段晶晶, 鄧婷, 巴一. 傳統腫瘤標志物在結直腸癌中的應用現狀. 腫瘤綜合治療電子雜志, 2020, 6(2): 1-6. | 
				                                                        
				                                                            
				                                                                | 20. | 劉慶睿, 姜憲. 結腸癌肝轉移患者臨床特征及預后危險因素分析: 基于 SEER 數據庫. 消化腫瘤雜志(電子版), 2022, 1(14): 65-70. | 
				                                                        
				                                                            
				                                                                | 21. | Zhao J, Zhu J, Huang C, et al. Impact of primary tumor resection on the survival of patients with unresectable colon cancer liver metastasis at different colonic subsites: a propensity score matching analysis. Acta Chir Belg, 2023, 123(2): 132-147. | 
				                                                        
				                                                            
				                                                                | 22. | Russolillo N, Sperti E, Langella S, et al. Impact of primary tumor location on patterns of recurrence and survival of patients undergoing resection of liver metastases from colon cancer. HPB (Oxford), 2020, 22(1): 116-123. | 
				                                                        
				                                                            
				                                                                | 23. | Hayama T, Ozawa T, Asako K, et al. Impact of colon cancer location on the prognostic significance of nutritional indexes and inflammatory markers. In vivo, 2021, 35(2): 1261-1269. | 
				                                                        
				                                                            
				                                                                | 24. | Mazaki J, Katsumata K, Sujino H, et al. Neutrophil-to-lymphocyte ratio as a prognostic factor for colon cancer in elderly patients: a propensity score analysis. Anticancer Res, 2021, 41(9): 4471-4478. | 
				                                                        
				                                                            
				                                                                | 25. | Xu SS, Li S, Xu HX, et al. Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer. World J Gastroenterol, 2020, 26(8): 828-838. | 
				                                                        
				                                                            
				                                                                | 26. | Guo Y, Shi D, Zhang J, et al. The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel significant prognostic factor for patients with metastatic prostate cancer undergoing cytoreductive radical prostatectomy. J Cancer, 2019, 10(1): 81-91. | 
				                                                        
				                                                            
				                                                                | 27. | 張利, 彭麗麗, 孫寧寧, 等. 治療前HALP評分對Ⅳ期無驅動基因NSCLC患者的預后意義. 現代腫瘤醫學, 2022, 18(30): 3310-3315. |